Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | RHOA | P61586 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6282689 | 0.93 | CYP3A4 (0.82) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| Phthalic Acid SCHEMBL23929049 | 0.88 | CYP3A4 (0.86) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| Phthalic Acid SCHEMBL710708 | 0.88 | CYP3A4 (0.86) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| Phthalic Acid SCHEMBL710707 | 0.88 | CYP3A4 (0.86) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| Benzene SCHEMBL7689916 | 0.88 | CYP3A4 (0.86) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| SCHEMBL87635 | 0.88 | CYP3A4 (0.86) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| SCHEMBL4072700 | 0.87 | CYP3A4 (0.72) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| SCHEMBL8587092 | 0.87 | CYP3A4 (0.72) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| Hydrochloric Acid SCHEMBL10627992 | 0.87 | CYP3A4 (0.83) | CYP3A4ALDH1A1TSHRHSD17B10RHOA | |
| Bicarbonate SCHEMBL20838539 | 0.87 | CYP3A4 (0.83) | CYP3A4ALDH1A1TSHRHSD17B10RHOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113946101-A | Photosensitive resin composition | 味之素株式会社 | 2022-01-18 | — | — | CN | disclosed |
| WO-2020066047-A1 | COMPOSITION FOR OPTICAL STEREOLITHOGRAPHY, STEREOLITHOGRAPHIC OBJECT, AND PRODUCTION METHOD THEREFOR | 岡本化学工業株式会社 | 2020-04-02 | — | — | WO | disclosed |
| EP-1812436-A1 | METABOLITES OF CERTAIN [1,4]DIAZEPINO[6,7,1-IJ]QUINOLINE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF | Wyeth (US) | 2007-08-01 | — | — | EP | disclosed |
| US-20060111305-A1 | Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof | WYETH (US) | 2006-05-25 | — | — | US | disclosed |
| WO-2006052886-A1 | METABOLITES OF CERTAIN [1,4]DIAZEPINO[6,7,1-IJ]QUINOLINE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF | WYETH (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006052886-A1 | METABOLITES OF CERTAIN [1,4]DIAZEPINO[6,7,1-IJ]QUINOLINE DERIVATIVES AND METHODS OF PREPARATION AND USE THEREOF | WYETH (US) | 2006-05-18 | — | — | WO | disclosed |
| EP-0880503-A1 | BALANOL ANALOGUES | Phytera Symbion ApS (DK) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997029091-A1 | BALANOL ANALOGUES | PHYTERA SYMBION APS (DK) | 1997-08-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111305-A1 | Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof | CYP4B1, CYP2D6, CYP2J2 | CYP3A4 14/4885ALDH1A1 132/4885TSHR 3944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.